MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0056893
Millifluous Pharmaceuticals Private Limited
Millifluous Pharmaceuticals Private Limited - trading in New Delhi, Delhi, India. Directors, charges & compliance details.
Revenue · FY 2024
₹4.56 Lakh
Latest filing
Net loss · FY 2024
₹2.03 Lakh
Net margin -44.6%
EBITDA · FY 2024
-₹1.86 Lakh
EBITDA margin -40.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹8 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Millifluous Pharmaceuticals Private Limited
Data last updated:
Millifluous Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 10 January 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2023PTC409777.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors including Shipra Das and Rimpa Das.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 55 2nd Floor Lane 2 Westend Marg Saidullajab, Near Saket Metro Station, New Delhi, Delhi, India – 110030.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.56 Lakh. For the same year it recorded a net loss of ₹2.03 Lakh (net margin -44.6%) and EBITDA of -₹1.86 Lakh (EBITDA margin -40.7%).
Millifluous Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0056893).
Company Details of Millifluous Pharmaceuticals Private Limited
CIN U51909DL2023PTC409777
Registration Number 409777
Incorporation Date 10 January 2023
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0056893
Recognitions & Rankings of Millifluous Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH. No. 55 2nd Floor Lane 2 Westend Marg Saidullajab, Near Saket Metro Station, New Delhi, Delhi, India – 110030
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Millifluous Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Millifluous Pharmaceuticals Private Limited
The main business activity of Millifluous Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Millifluous Pharmaceuticals Private Limited FY 2025 filings available
Millifluous Pharmaceuticals Private Limited reported revenue of ₹4.56 Lakh for FY 2024.
Revenue · FY 2024
₹4.56 Lakh
Net loss · FY 2024
₹2.03 Lakh margin -44.6%
EBITDA · FY 2024
-₹1.86 Lakh margin -40.7%
Financial Statement Summary of Millifluous Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹1.86 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹2.03 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Millifluous Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -40.7% | •••• |
| Net Profit Margin | -44.6% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Millifluous Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Millifluous Pharmaceuticals Private Limited
Millifluous Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shipra Das | Director | 10 Jan 2023 | 3 Years 9 Months | Current |
| Rimpa Das | Director | 10 Jan 2023 | 3 Years 9 Months | Current |
| Sampita Biswas Also directs: Odb Realty Private Limited | Director | 10 Jan 2023 | 3 Years 9 Months | Current |
| Snigdha Dey Dutta | Director | 03 Mar 2025 | 1 Years 7 Months | Current |
Peer Comparison of Millifluous Pharmaceuticals Private Limited
Millifluous Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Unios Pharmaceuticals Private Limited | ₹4.57 Lakh (FY 2024) | •••• | •••• | -9.0% | •••• | Nagpur, Maharashtra, India |
| Wellbecure Pharmaceuticals Private Limited | ₹4.57 Lakh (FY 2025) | •••• | •••• | 14.0% | •••• | Varanasi, Uttar Pradesh, India |
| Astral Pharmaceuticals Private Limited | ₹4.57 Lakh (FY 2025) | •••• | •••• | 50.0% | •••• | Mumbai, Maharashtra, India |
| Accost Pharmaceuticals (India) Private Limited | ₹4.57 Lakh (FY 2024) | •••• | •••• | -27.0% | •••• | Rajendra Nagar, Patna, Bihar, India |
| Dare and Vision Pharmaceuticals Private Limited | ₹4.56 Lakh (FY 2024) | •••• | •••• | 72.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Millifluous Pharmaceuticals Private Limited this company | ₹4.56 Lakh (FY 2024) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Folk Pharmaceuticals Private Limited | ₹4.55 Lakh (FY 2024) | •••• | •••• | •••• | Patna, Bihar, India | |
| Klug Pharmaceuticals Private Limited | ₹4.54 Lakh (FY 2024) | •••• | •••• | -50.0% | •••• | Jaipur, Rajasthan, India |
| Klarzen Pharmaceuticals Private Limited | ₹4.53 Lakh (FY 2025) | •••• | •••• | 155.0% | •••• | Delhi, India |
| VL Pharmaceuticals Private Limited | ₹4.52 Lakh (FY 2019) | •••• | •••• | 133.0% | •••• | Lucknow, Uttar Pradesh, India |
| Great India Pharmaceuticals Private Limited. | ₹4.5 Lakh (FY 2025) | •••• | •••• | •••• | Ganjam, Odisha, India |
Peers are the five companies nearest above and the five nearest below Millifluous Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Millifluous Pharmaceuticals Private Limited
Millifluous Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Millifluous Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Millifluous Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Millifluous Pharmaceuticals Private Limited
Millifluous Pharmaceuticals Private Limited has 5 board changes on record since 2023: 4 appointments and 1 cessation. The latest: Chandra Das ceased to be Director on 04 Mar 2025.
AGM
Millifluous Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Millifluous Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Chandra Das ceased to be Director.
Appointed
Snigdha Dey Dutta was appointed as Director.
Appointed
Rimpa Das was appointed as Director.
Appointed
Sampita Biswas was appointed as Director.
Appointed
Shipra Das was appointed as Director.
Incorporation
10 Jan 2023
Millifluous Pharmaceuticals Private Limited was registered on 10 Jan 2023 with Roc Delhi I & aged 3 years 9 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Millifluous Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Millifluous Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Millifluous Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Millifluous Pharmaceuticals Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Millifluous Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Millifluous Pharmaceuticals Private Limited
Millifluous Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 10 January 2023 (3+ years old) and is registered under CIN U51909DL2023PTC409777.
Millifluous Pharmaceuticals reported revenue of ₹4.56 Lakh for FY 2024.
Millifluous Pharmaceuticals has 4 current directors:
- Shipra Das - Director
- Rimpa Das - Director
- Sampita Biswas - Director
- Snigdha Dey Dutta - Director
Millifluous Pharmaceuticals reported a net loss of ₹2.03 Lakh (net margin -44.6%) and EBITDA of -₹1.86 Lakh (EBITDA margin -40.7%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Millifluous Pharmaceuticals is U51909DL2023PTC409777. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Millifluous Pharmaceuticals was incorporated on 10 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Millifluous Pharmaceuticals by revenue are Unios Pharmaceuticals Private Limited, Wellbecure Pharmaceuticals Private Limited, Astral Pharmaceuticals Private Limited, Accost Pharmaceuticals (India) Private Limited, Dare and Vision Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Chandra Das ceased to be Director on 04 Mar 2025. Snigdha Dey Dutta was appointed as Director on 03 Mar 2025. Rimpa Das was appointed as Director on 10 Jan 2023. Millifluous Pharmaceuticals has 5 board changes on record in total.
Yes, Millifluous Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0056893).
The registered office of Millifluous Pharmaceuticals is at H. No. 55 2nd Floor Lane 2 Westend Marg Saidullajab, Near Saket Metro Station, New Delhi, Delhi, India – 110030.
Millifluous Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh.